Q3 2025 Beiersdorf AG Earnings Call Transcript
Key Points
- Beiersdorf AG (BDRFF)'s Derma business achieved strong double-digit growth of 12.4%, driven by successful product launches like Epicelline and Thiamidol.
- The company reported a positive organic sales growth of 2.1% in its consumer business for Q3, with Skin Care organic sales growth increasing to 4%.
- E-commerce continues to be a key growth driver, with organic sales growth of 16.6% in the first nine months and 19.2% in Q3.
- La Prairie returned to growth in Q3, supported by improved momentum in China, achieving a positive organic sales growth of 1.6%.
- The strategic repositioning of NIVEA in China was completed, and the brand is already back to growth in October, setting the stage for acceleration in Q4.
- NIVEA faced pressure from a weaker mass market environment, especially in emerging markets, resulting in an organic sales decline of 0.4% in Q3.
- The overall market environment remains challenging, with a further deterioration in emerging markets affecting the core of Beiersdorf's mass market business.
- The automotive segment continues to navigate a complex and volatile market environment, impacting Beiersdorf's performance.
- The company's performance was impacted by unfavorable foreign exchange effects, leading to a slight decline in nominal sales.
- Beiersdorf AG (BDRFF) adjusted its full-year guidance to around 2.5% organic sales growth for the consumer segment, reflecting ongoing market challenges.
Ladies and gentlemen, welcome to the Q3 results 2025 conference call of Beiersdorf AG. I'm Moore, the Chorus call operator. I would like to remind you that all the participants are in listen-only mode and the conference is being recorded. The presentation will be followed by a question-and-answer session. (Operator Instructions) The conference must not be recorded for publication or broadcast.
At this time, it's my pleasure to hand over to Christopher Sheldon, Head of Investor Relations. Please go ahead, sir.
Good morning, everyone, and thank you for joining us for our third quarter conference call. I'm here with our CEO, Vincent Warnery; and our CFO, Astrid Hermann. As always, we will start with the presentation of our sales performance of the quarter and the first nine months of the year, followed by a Q&A session. And with that, I'd like to hand over to Vincent.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
